Why Moderna Stock Is Spiking Today
Shares of the large-cap biotech Moderna (NASDAQ: MRNA) rose by as much as 10.9% in premarket trading Monday morning. The biotech's stock appears to be rocketing higher today in response to a Sunday BBC interview with the company's chief medical officer, Dr. Paul Burton.
During the interview, Burton noted that Moderna was already hard at work evaluating a higher-dose booster shot for the highly mutated omicron variant. He also said that an entirely new vaccine tailor-made for this variant of concern, if warranted, could be ready as soon as early 2022.
Image source: Getty Images.
Source Fool.com
